bg
R

Rezolute (RZLT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Rezolute (RZLT)

Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of conge... Read more

  • USD4.22
  • USD4.38
  • USD4.10
  • USD6.19
  • 21.80%
  • --
  • 100.00
  • 848.91k
  • 359M
  • 2.22
  • 10.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.